The global anti-influenza virus Chinese medicine market is anticipated to grow at a CAGR of4.6% during the forecast period (2022-2028). Influenza (flu) is a highly contagious respiratory illness caused by influenza viruses infecting the nose, throat, and lungs.The rise in influenza incidences across the globe is a major factor driving the growth of the anti-influenza virus Chinese medicine market. In 2020, the influenza virus caused 70 deaths in China approximately 0.5 out of every ten million people died as a result of the infection. The market is likely to benefit from the high development potential displayed by rising economies such as China,that has a huge population base and prominent epidemiology of influenza infection. Oseltamivir, zanamivir, and peramivir are the most often prescribed anti-influenza medications in China.
Increasing usage of traditional Chinese medicine is propelling the market growth of anti-influenza virus Chinese medicine. in October 2021, according to science direct anti-influenza medications that are recommended by international recommendations and commercialized in China are mostly neuraminidase inhibitors, that work by interfering with the virus’s release. In the prevention and treatment of infectious diseases, traditional Chinese medicine (TCM) provides a wealth of theoretical and practical knowledge. TCM’s ancient texts describe flu-like illnesses and offer precise therapeutic recommendations. Chinese medicines also contain a number of active components that are helpful against the influenza virus, according to modern pharmacological investigations. Clinical studies show that combining Chinese patent medicine, Chinese herbal compounds, and Chinese and Western medicine in the treatment of influenza has a significant effect on shortening the course of the disease, reducing the severity of upper respiratory tract infection, and alleviating influenza symptoms. Chinese medicine, when used in conjunction with Western medicine, can help to lower the dosage of Western medicine, as well as its harmful and adverse effects. Secondary pneumonia is also on the decline.
Additionally, according to research conducted by ScienceDirect in which Antiwei, a traditional Chinese medication, was studied for its efficacy and safety in the treatment of influenza. It was found that Antiwei was found to be efficacious and well-tolerated in the treatment of people with spontaneous influenza infection. In the treatment of influenza, Antiwei is a clinically useful intervention. In addition, there are an increasing number of government campaigns to raise knowledge about influenza medications and prevention. Another factor driving the market’s global expansion is the presence of a strong pipeline for antiviral drugs. The Chinese Ministry of Health released ‘Guidelines for Pandemic (H1N1) Influenza Management,’ that recommended a number of Chinese herbs for the treatment of type A H1N1 influenza, including herbal products extracted from natural herbs, Chinese patent medicine (including herbal injection), and principles for individually prescribed herbal decoctions.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Global Anti-Influenza Virus Chinese Medicine Market at https://orionmarketreports.com/request-sample/?id=111126&submit=Request+Sample%0D%0A
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Type
- By Indication
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape-Beijing Tong Ren Tang Medicine Co. Ltd., China Resources Pharmaceutical Group Ltd., China Traditional Chinese Medicine Holdings Co. Ltd., GreenValley Inc., Tasly Pharmaceuticals, Inc., among others.
A full report is available at: https://orionmarketreports.com/global-anti-influenza-virus-chinese-medicine-market/111126/
Global Anti-influenzaVirus Chinese Medicine Market Report by Segment
By Type
- Capsule
- Injection
- Oral Solution
- Others
By Application
- Infectious Disease
- Cancer
- Other Indication
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
